Genzyme takes on Mylan in patent suit

28-09-2016

Genzyme takes on Mylan in patent suit

garajstock / Shutterstock.com

Biotechnology company Genzyme has sued generic manufacturer Mylan in a lawsuit claiming that the company has infringed one of Genzyme’s patents covering the Clolar (clofarabine) injection drug.


patent, patent infringement, Genzyme, Mylan, ANDA, generics, clofarabine

LSIPR